Mosapride + domperidone
ApprovedUNKNOWN 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Diabetic Gastroparesis
Conditions
Diabetic Gastroparesis
Trial Timeline
Oct 1, 2014 → Dec 1, 2015
NCT ID
NCT02264587About Mosapride + domperidone
Mosapride + domperidone is a approved stage product being developed by Sumitomo Pharma for Diabetic Gastroparesis. The current trial status is unknown. This product is registered under clinical trial identifier NCT02264587. Target conditions include Diabetic Gastroparesis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02264587 | Approved | UNKNOWN |
Competing Products
20 competing products in Diabetic Gastroparesis